Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Veterinary Medicine and Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hum Reprod. 2018 Dec 1;33(12):2249-2255. doi: 10.1093/humrep/dey316.
Can transplanted primate testicular cells form seminiferous tubules de novo, supporting complete spermatogenesis?
Cryopreserved testicular cells from a prepubertal monkey can reorganize in an adult monkey recipient testis forming de novo seminiferous tubular cords supporting complete spermatogenesis.
De novo morphogenesis of testicular tissue using aggregated cells from non-primate species grafted either subcutaneously or in the testis can support spermatogenesis.
STUDY DESIGN, SIZE, DURATION: Two postpubertal rhesus monkeys (Macaca mulatta) were given testicular irradiation. One monkey was given GnRH-antagonist treatment from 8 to 16 weeks after irradiation, while the other received sham injections. At 16 weeks, cryopreserved testicular cells from two different prepubertal monkeys [43 × 106 viable (Trypan-blue excluding) cells in 260 μl, and 80 × 106 viable cells in 400 μl] were transplanted via ultrasound-guided injections to one of the rete testis in each recipient, and immune suppression was given. The contralateral testis was sham transplanted. Testes were analyzed 9 months after transplantation.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Spermatogenic recovery was assessed by testicular volume, weight, histology and immunofluorescence. Microsatellite genotyping of regions of testicular sections obtained by LCM determined whether the cells were derived from the host or transplanted cells.
Transplanted testis of the GnRH-antagonist-treated recipient, but not the sham-treated recipient, contained numerous irregularly shaped seminiferous tubular cords, 89% of which had differentiating germ cells, including sperm in a few of them. The percentages of donor genotype in different regions of this testis were as follows: normal tubule, 0%; inflammatory, 0%; abnormal tubule region, 67%; whole interior of abnormal tubules, >99%; adluminal region of the abnormal tubules, 92%. Thus, these abnormal tubules, including the enclosed germ cells, were derived de novo from the donor testicular cells.
Not applicable.
LIMITATIONS, REASONS FOR CAUTION: The de novo tubules were observed in only one out of the two monkeys transplanted with prepubertal donor testicular cells.
These findings may represent a promising strategy for restoration of fertility in male childhood cancer survivors. The approach could be particularly useful in those exposed to therapeutic agents that are detrimental to the normal development of the tubule somatic cells affecting the ability of the endogenous tubules to support spermatogenesis, even from transplanted spermatogonial stem cells.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by research grants P01 HD075795 from Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD/NIH) to K.E.O and Cancer Center Support Grant P30 CA016672 from NCI/NIH to The University of Texas MD Anderson Cancer Center. The authors declare that they have no competing interests.
移植的灵长类睾丸细胞能否重新形成生精小管,支持完整的精子发生?
冷冻保存的来自青春期前猴子的睾丸细胞可以在成年猴子受者睾丸中重新组织,形成新的生精小管索,支持完整的精子发生。
使用非灵长类物种的聚集细胞进行的睾丸组织的新生形态发生,无论是皮下还是睾丸内移植,都可以支持精子发生。
研究设计、大小、持续时间:两只青春期后的恒河猴(Macaca mulatta)接受了睾丸照射。一只猴子在照射后 8 至 16 周接受 GnRH 拮抗剂治疗,而另一只接受假注射。16 周时,通过超声引导注射将来自两个不同青春期前猴子的冷冻保存睾丸细胞[43×106 个活(台盼蓝排除)细胞在 260μl 中,和 80×106 个活细胞在 400μl]移植到每个受者的一个 rete testis 中,并给予免疫抑制。对侧睾丸进行假移植。移植后 9 个月分析睾丸。
参与者/材料、设置、方法:通过睾丸体积、重量、组织学和免疫荧光评估精子发生的恢复情况。通过 LCM 获得的睾丸切片的微卫星基因分型确定细胞是来自宿主还是移植细胞。
接受 GnRH 拮抗剂治疗的受者的移植睾丸中含有许多不规则形状的生精小管索,其中 89%具有分化的生殖细胞,其中一些包含精子。该睾丸不同区域的供体基因型百分比如下:正常小管,0%;炎症,0%;异常小管区域,67%;异常小管的整个内部,>99%;异常小管的管腔区域,92%。因此,这些异常小管,包括封闭的生殖细胞,是从头状腺细胞衍生而来的。
不适用。
局限性、谨慎的原因:仅在接受青春期前供体睾丸细胞移植的两只猴子中的一只中观察到新生小管。
这些发现可能代表了恢复男性儿童癌症幸存者生育能力的有希望的策略。该方法在那些暴露于对管状体细胞正常发育有害的治疗剂的情况下尤其有用,这些剂会影响内源性小管支持精子发生的能力,即使是来自移植的精原干细胞。
研究资金/竞争利益:这项工作得到了 Eunice Kennedy Shriver 国家儿童健康与人类发育研究所(NICHD/NIH)P01 HD075795 研究基金和美国国立卫生研究院癌症中心支持的 P30 CA016672 癌症中心资助的支持。作者声明他们没有竞争利益。